CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $14.13B, above the global median of $1.14B
- PositionReturn on equity is 34%, higher than 95% of its Medical Instruments & Supplies peers (median 5.4%)
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
14.13BUSDvs all stocks (USD)
Trailing P/E
10.50xvs Medical Instruments & Supplies peers
Revenue (TTM)
8.31BUSDvs all stocks (USD)
Profit Margin
17.26%vs Medical Instruments & Supplies peers
Beta
0.7030xvs all stocks
52-Week Change
18.10%vs all stocks
Forward Annual Dividend Yield
0.00%vs all stocks
Market Capitalization
14.13BUSDvs all stocks (USD)
Enterprise Value
19.50BUSDvs all stocks (USD)
Trailing P/E
10.50xvs Medical Instruments & Supplies peers
Forward P/E
11.81xvs Medical Instruments & Supplies peers
PEG Ratio
5.46xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
1.76xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
3.04xvs Medical Instruments & Supplies peers
Enterprise to Revenue
2.35xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
17.12xvs Medical Instruments & Supplies peers
Gross Margin
58.22%vs Medical Instruments & Supplies peers
Profit Margin
17.26%vs Medical Instruments & Supplies peers
Operating Margin
9.78%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
2.70%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
33.96%vs Medical Instruments & Supplies peers
Revenue (TTM)
8.31BUSDvs all stocks (USD)
Revenue per Share (TTM)
47.79USDUpdated Oct 28, 2026Quarterly Revenue Growth
2.20%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
4.55BUSDvs all stocks (USD)
EBITDA (TTM)
1.00BUSDvs all stocks (USD)
Net Income (TTM)
1.43BUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
2.20%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
209.00MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
489.00MUSDvs all stocks (USD)
Forward Annual Dividend Yield
0.00%vs all stocks
Trailing Annual Dividend Rate
0.00USDUpdated Oct 28, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Revenue
8.32BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
3.87BUSDFY2025 · Dec 31, 2025Gross Profit
4.45BUSDFY2025 · Dec 31, 2025Operating Income
632.00MUSDvs all stocks (USD)
Pre-tax Income
1.71BUSDFY2025 · Dec 31, 2025Income Tax Expense
157.00MUSDFY2025 · Dec 31, 2025Net Income
1.56BUSDFY2025 · Dec 31, 2025EBIT
2.06BUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.08BUSDFY2025 · Dec 31, 2025Research & Development
739.00MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
3.08BUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
347.00MUSDFY2025 · Dec 31, 2025EPS (Basic)
8.94USDFY2025 · Dec 31, 2025EPS (Diluted)
8.88USDFY2025 · Dec 31, 2025Basic Shares Outstanding
174.10MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
174.10MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
1.56BUSDFY2025 · Dec 31, 2025Operating Cash Flow
1.82BUSDFY2025 · Dec 31, 2025Free Cash Flow
1.45BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
878.00MUSDFY2025 · Dec 31, 2025Income Tax Paid
181.00MUSDFY2025 · Dec 31, 2025Interest Paid
181.00MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
1.56BUSDFY2025 · Dec 31, 2025Depreciation & Amortization
489.00MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-120.00MUSDFY2025 · Dec 31, 2025Stock-based Compensation
161.00MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-111.00MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
78.00MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
104.00MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-333.00MUSDFY2025 · Dec 31, 2025Capital Expenditures
-379.00MUSDFY2025 · Dec 31, 2025Net Acquisitions
3.19BUSDFY2025 · Dec 31, 2025Other Investing Activity
-18.00MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
2.80BUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
-3.07BUSDFY2025 · Dec 31, 2025Other Financing Charges
13.00MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-3.06BUSDFY2025 · Dec 31, 2025Shares Outstanding
170.11MSharesUpdated Oct 28, 2026Float Shares
144.09MSharesUpdated Oct 28, 2026Shares Short
4.89MSharesUpdated Oct 28, 2026Short Ratio
5.55daysvs all stocks
Short % of Shares Outstanding
3.39%vs all stocks
% Held by Insiders
15.34%vs all stocks
% Held by Institutions
75.96%vs all stocks
Total Cash (MRQ)
403.00MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
2.37USDUpdated Oct 28, 2026Total Debt (MRQ)
5.30BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
1.10xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.02xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
28.22USDUpdated Oct 28, 2026Total Assets
14.29BUSDvs all stocks (USD)
Total Current Assets
3.86BUSDFY2025 · Dec 31, 2025Total Liabilities
9.24BUSDFY2025 · Dec 31, 2025Total Non-current Assets
10.44BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
6.11BUSDFY2025 · Dec 31, 2025Total Current Liabilities
3.14BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
878.00MUSDFY2025 · Dec 31, 2025Accounts Receivable
1.03BUSDFY2025 · Dec 31, 2025Inventory
1.07BUSDFY2025 · Dec 31, 2025Accounts Payable
687.00MUSDFY2025 · Dec 31, 2025Deferred Revenue
621.00MUSDFY2025 · Dec 31, 2025Other Current Liabilities
634.00MUSDFY2025 · Dec 31, 2025Long-term Debt
5.04BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
546.00MUSDFY2025 · Dec 31, 2025Common Stock (Book)
2.00MUSDFY2025 · Dec 31, 2025Retained Earnings
1.80BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
5.05BUSDvs all stocks (USD)
52-Week Low
62.38USDUpdated Oct 28, 202652-Week High
94.16USDUpdated Oct 28, 202652-Week Change
18.10%vs all stocks
Beta
0.7030xvs all stocks
50-Day MA
88.51USDUpdated Oct 28, 2026200-Day MA
78.38USDUpdated Oct 28, 2026Avg 10-Day Volume
1.02MSharesUpdated Oct 28, 2026Avg 30-Day Volume
987.37KSharesUpdated Oct 28, 2026Diluted EPS (TTM)
8.17USDUpdated Oct 28, 2026Other Income / Expense
1.43BUSDFY2025 · Dec 31, 20252 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Return on equity is 34%, higher than 95% of its Medical Instruments & Supplies peers (median 5.4%)Significant
Return on equity: 0.34Industry median: 0.05Industry P95: 0.23Peers compared: 36.00
Current ratio is 1.02×, lower than 95% of its Medical Instruments & Supplies peers (median 2.69×)Significant
Current ratio: 1.02Industry median: 2.69Industry P5: 1.20Peers compared: 36.00
Debt-to-equity is 1.1×, higher than 95% of its Medical Instruments & Supplies peers (median 0.16×)Significant
Debt-to-equity: 1.10Industry median: 0.16Industry P95: 1.00Peers compared: 36.00
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 1,434,000,000Operating Cash Flow (USD, TTM): 209,000,000
Financial Health
Altman Z-Score 2.21: grey zoneSignificant
Altman Z-Score: 2.21
High earnings qualityNotable
Earnings Quality Score: 0.54
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $14.13B, above the global median of $1.14BNotable
Market cap (USD): 14,125,165,032Global Median: 1,138,450,684.034
Revenue is $8.31B, above the global median of $562.3MNotable
Revenue (USD): 8,310,000,128Global Median: 562,304,852.367
Levered free cash flow is $489M, above the global median of $18.69MNotable
Levered free cash flow (USD): 489,000,000Global Median: 18,689,872.41
Companies that share the same coordination system — how they create, deliver, or capture value.
Jiangsu Zhongtian Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Power Assets Holdings Limited
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Datang International Power Generation Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Industries Qatar Q.P.S.C.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
EDP Renováveis S.A.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Nio Inc.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Tupras Turkiye Petrol Rafinerileri A.S.
Tier 1ProductionThroughput-Bound ConversionFlowRule
China Three Gorges Renewables (Group) Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Carpenter Technology Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
MKS Instruments Inc.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
TORM PLC
2 interpretationsCash-Flow Ratios ElevatedFCF Ratios Elevated
T. Rowe Price Group, Inc.
2 interpretationsCash-Flow Ratios ElevatedFCF Ratios Elevated
TransMedics Group Inc.
2 interpretationsCash-Flow Ratios ElevatedFCF Ratios Elevated